✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (243 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
40.78
4,28,581
67.22
1,67,051
59.98
1,28,367
22.11
1,20,289
18.09
1,04,421
21.71
93,867
18.89
92,946
50.63
88,650
19.72
68,035
28.35
66,931
39.47
59,563
54.57
55,111
80.37
54,968
104
50,664
45.96
43,900
44.66
37,147
80.17
36,179
34.07
33,174
39.50
28,375
35.67
28,196
33.71
26,735
-
23,003
27.40
23,000
113
22,535
52.71
21,909
-
21,664
87.06
20,907
81.54
20,209
484
19,356
52.81
19,118
65.01
18,621
27.46
17,418
35.34
16,881
10.10
15,538
135
15,532
24.88
14,647
44.64
14,461
61.56
13,789
26.23
13,455
28.53
12,720
20.63
10,944
48.46
10,559
77.75
10,447
23.68
9,786
50.10
9,773
30.81
9,453
26.46
9,326
24.61
8,653
20.58
8,177
55.07
7,638
30.55
6,888
21.14
6,703
47.27
6,487
26.71
6,403
32.39
5,907
121
5,080
-
4,908
81.09
4,237
34.03
4,235
86.20
4,163
-
3,852
17.61
3,793
17.89
3,561
40.47
3,526
62.12
3,462
25.21
3,439
23.06
3,399
312
3,158
35.28
3,121
456
2,926
34.35
2,898
7.75
2,510
20.80
2,410
22.73
2,242
-
2,191
-
2,047
170
2,034
33.24
1,884
24.37
1,641
38.52
1,634
14.52
1,592
22.73
1,507
55.93
1,455
22.35
1,409
30.92
1,356
21.65
1,341
25.72
1,316
55.21
1,107
14.95
1,051
12.05
964
-
946
18.96
930
7.90
885
45.13
880
25.41
840
39.45
816
18.93
814
40.88
807
20.49
793
37.26
765
3.19
762
-
758
35.67
628
37.71
602
21.24
586
28.66
562
27.03
552
39.86
533
49.70
532
14.56
480
-
472
69.31
458
-
432
37.73
428
22.39
419
38.03
399
-
370
71.46
362
55.04
362
44.67
359
97.26
358
29.97
352
37.93
333
18.62
317
32.93
316
75.91
312
137
283
24.57
283
90.42
278
36.82
274
25.42
249
36.26
241
9.60
233
-
223
21.86
213
21.38
206
44.87
203
-
199
51.88
186
-
176
9.27
173
14.07
173
660
171
36.23
165
9.32
162
30.07
161
15.88
153
139
148
-
145
10.52
143
17.83
143
31.44
142
29.68
139
11.91
131
17.12
117
37.07
115
15.76
113
11.58
112
15.90
108
-
105
176
102
20.06
99
42.11
98
25.60
96
19.10
92
30.02
89
12.39
89
11.53
89
14.42
88
-
87
48.54
76
17.06
74
-
70
6.41
69
57.61
69
-
68
16.01
67
12.44
62
77.89
61
30.82
60
14.76
60
8.26
60
91.96
58
266
54
14.56
54
18.97
54
3.50
53
-
53
15.87
53
-
45
106
45
95.31
42
-
41
-
40
17.07
40
-
39
-
38
26.82
38
9.02
37
23.78
37
81.04
37
10.51
37
18.35
35
-
35
13.43
33
-
32
8.80
30
161
29
7.29
29
32.98
28
37.72
28
121
27
-
27
11.86
25
22.48
22
66.75
20
29.25
19
54.54
19
-
19
-
17
15.32
16
64.31
15
-
15
-
14
-
14
-
13
-
12
49.98
12
11.04
11
24.54
11
-
10
-
10
87.37
7
709
6
287
6
43.01
6
-
5
79.18
5
-
5
-
5
-
4
-
3
-
2
Showing 5 243 of 243 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material